Direkt zum Inhalt
Merck
  • Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.

Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.

Hepatology (Baltimore, Md.) (2014-03-29)
Freimut Schliess, Stefan Hoehme, Sebastian G Henkel, Ahmed Ghallab, Dominik Driesch, Jan Böttger, Reinhard Guthke, Michael Pfaff, Jan G Hengstler, Rolf Gebhardt, Dieter Häussinger, Dirk Drasdo, Sebastian Zellmer
ZUSAMMENFASSUNG

The impairment of hepatic metabolism due to liver injury has high systemic relevance. However, it is difficult to calculate the impairment of metabolic capacity from a specific pattern of liver damage with conventional techniques. We established an integrated metabolic spatial-temporal model (IM) using hepatic ammonia detoxification as a paradigm. First, a metabolic model (MM) based on mass balancing and mouse liver perfusion data was established to describe ammonia detoxification and its zonation. Next, the MM was combined with a spatial-temporal model simulating liver tissue damage and regeneration after CCl4 intoxication. The resulting IM simulated and visualized whether, where, and to what extent liver damage compromised ammonia detoxification. It allowed us to enter the extent and spatial patterns of liver damage and then calculate the outflow concentrations of ammonia, glutamine, and urea in the hepatic vein. The model was validated through comparisons with (1) published data for isolated, perfused livers with and without CCl4 intoxication and (2) a set of in vivo experiments. Using the experimentally determined portal concentrations of ammonia, the model adequately predicted metabolite concentrations over time in the hepatic vein during toxin-induced liver damage and regeneration in rodents. Further simulations, especially in combination with a simplified model of blood circulation with three ammonia-detoxifying compartments, indicated a yet unidentified process of ammonia consumption during liver regeneration and revealed unexpected concomitant changes in amino acid metabolism in the liver and at extrahepatic sites. The IM of hepatic ammonia detoxification considerably improves our understanding of the metabolic impact of liver disease and highlights the importance of integrated modeling approaches on the way toward virtual organisms.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ammoniak -Lösung, 7 N in methanol
Sigma-Aldrich
Harnstoff, powder, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
Harnstoff -Lösung, BioUltra, ~8 M in H2O
Supelco
Harnstoff, 8 M (after reconstitution with 16 mL high purity water)
Sigma-Aldrich
Harnstoff, ACS reagent, 99.0-100.5%
Sigma-Aldrich
Ammoniak -Lösung, 0.4 M in dioxane
Sigma-Aldrich
Ammoniak -Lösung, 2.0 M in ethanol
Sigma-Aldrich
Ammoniak, anhydrous, ≥99.98%
Sigma-Aldrich
Harnstoff, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
Hämatoxylin
Sigma-Aldrich
Ammoniak -Lösung, 4 M in methanol
Sigma-Aldrich
Ammoniak -Lösung, 0.4 M in THF
Sigma-Aldrich
Ammoniak -Lösung, 2.0 M in methanol
Sigma-Aldrich
Harnstoff, suitable for electrophoresis
Sigma-Aldrich
Harnstoff, BioUltra, for molecular biology, 99% (T)
Sigma-Aldrich
Hämatoxylin, certified by the Biological Stain Commission
Sigma-Aldrich
Harnstoff, ReagentPlus®, ≥99.5%, pellets
Sigma-Aldrich
Ammoniak -Lösung, 2.0 M in isopropanol
USP
Harnstoff, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Harnstoff -Lösung, 40 % (w/v) in H2O
Sigma-Aldrich
Harnstoff, meets USP testing specifications
Sigma-Aldrich
Harnstoff, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, 99.0-101.0% (calc. on dry substance)
Sigma-Aldrich
Ammoniak, puriss., anhydrous, ≥99.95%
Sigma-Aldrich
Harnstoff, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Millipore
Harnstoff -Lösung, suitable for microbiology, 40% in H2O
Supelco
Harnstoff, analytical standard
Sigma-Aldrich
Ammoniak-14N, 99.99 atom % 14N
Sigma-Aldrich
Harnstoff-12C, 99.9 atom % 12C
Harnstoff, European Pharmacopoeia (EP) Reference Standard